These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18228563)

  • 21. The impact of the President's Emergency Plan for AIDS Relief on expansion of HIV care services for adult patients in western Kenya.
    Wools-Kaloustian K; Kimaiyo S; Musick B; Sidle J; Siika A; Nyandiko W; Einterz R; Tierney WM; Yiannoutsos CT
    AIDS; 2009 Jan; 23(2):195-201. PubMed ID: 19098489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of unified procedures as implemented in the Canadian Quality Assurance Program for T lymphocyte subset enumeration. Participating Flow Cytometry Laboratories of the Canadian Clinical Trials Network for HIV/AIDS Therapies.
    Bergeron M; Faucher S; Minkus T; Lacroix F; Ding T; Phaneuf S; Somorjai R; Summers R; Mandy F
    Cytometry; 1998 Oct; 33(2):146-55. PubMed ID: 9773875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Why and how to monitor the cost and evaluate the cost-effectiveness of HIV services in countries.
    Beck EJ; Santas XM; Delay PR
    AIDS; 2008 Jul; 22 Suppl 1():S75-85. PubMed ID: 18664958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Decentralization of the immunological monitoring of people living with HIV/AIDS in a limiting setting with a low HIV seroprevalence: the experience of Senegal].
    Diaw PA; Sylla Niang M; Touré Kane C; Dieye TD; Diop Ndiaye H; Wade AS; Dieye A; Mboup S
    Ann Biol Clin (Paris); 2008; 66(4):409-16. PubMed ID: 18725342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-cost enumeration of CD4+ T cells using a density-based negative selection method (RosetteSep) for the monitoring of HIV-infected individuals in non-OECD countries.
    Bold A; Wurth R; Keller T; Trahorsch U; Voigt P; Schubert S; Sack U
    Cytometry A; 2008 Jan; 73(1):28-35. PubMed ID: 18061955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The global health and diagnostic (flow) cytometry--breakthroughs in HIV and tuberculosis.
    Merson M; Denny TN
    Cytometry B Clin Cytom; 2008; 74 Suppl 1():S4-5. PubMed ID: 18307250
    [No Abstract]   [Full Text] [Related]  

  • 27. Free care at the point of service delivery: a key component for reaching universal access to HIV/AIDS treatment in developing countries.
    Souteyrand YP; Collard V; Moatti JP; Grubb I; Guerma T
    AIDS; 2008 Jul; 22 Suppl 1():S161-8. PubMed ID: 18664948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The economics of health care in developing countries: what the fight against the AIDS epidemics has changed].
    Moatti JP
    C R Biol; 2008 Dec; 331(12):964-72. PubMed ID: 19027697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The changing pattern of "smart" flow cytometry (S-FC) to assist the cost-effective diagnosis of HIV, tuberculosis, and leukemias in resource-restricted conditions.
    Janossy G
    Biotechnol J; 2008 Jan; 3(1):32-42. PubMed ID: 18064612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reframing the HIV/AIDS debate in developing countries I: setting the scene.
    Couper ID
    Rural Remote Health; 2004; 4(2):280. PubMed ID: 15885000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tackling Malawi's human resources crisis.
    Palmer D
    Reprod Health Matters; 2006 May; 14(27):27-39. PubMed ID: 16713877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strengthening national laboratory health systems in the Caribbean Region.
    Alemnji GA; Branch S; Best A; Kalou M; Parekh B; Waruiru W; Milstrey E; Conn W; Nkengasong JN; Lecher S
    Glob Public Health; 2012; 7(6):648-60. PubMed ID: 22519703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health economics and applications in developing countries.
    Schultz TP
    J Health Econ; 2004 Jul; 23(4):637-41. PubMed ID: 15587690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The World Bank discovers AIDS.
    Whiteside A
    AIDS Anal Afr; 2000 Jan; 10(4):4-5. PubMed ID: 12349438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Has donor prioritization of HIV/AIDS displaced aid for other health issues?
    Shiffman J
    Health Policy Plan; 2008 Mar; 23(2):95-100. PubMed ID: 18156161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimizing resource allocation for HIV/AIDS prevention programmes: an analytical framework.
    Bautista-Arredondo S; Gadsden P; Harris JE; Bertozzi SM
    AIDS; 2008 Jul; 22 Suppl 1():S67-74. PubMed ID: 18664956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The public health approach to antiretroviral treatment (ART) service scale-up in Ethiopia: the first two years of free ART, 2005-2007.
    Assefa Y; Kloos H
    Ethiop Med J; 2008 Oct; 46(4):401-6. PubMed ID: 19271406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Micro- and nanotechnology for HIV/AIDS diagnostics in resource-limited settings.
    Damhorst GL; Watkins NN; Bashir R
    IEEE Trans Biomed Eng; 2013 Mar; 60(3):715-26. PubMed ID: 23512111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Critical role of developing national strategic plans as a guide to strengthen laboratory health systems in resource-poor settings.
    Nkengasong JN; Mesele T; Orloff S; Kebede Y; Fonjungo PN; Timperi R; Birx D
    Am J Clin Pathol; 2009 Jun; 131(6):852-7. PubMed ID: 19461093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Provider-initiated HIV testing and counseling of TB patients--Livingstone District, Zambia, September 2004-December 2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Mar; 57(11):285-9. PubMed ID: 18354372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.